---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-032444"
form_type: "8-K"
ticker: "CHRN"
cik: "0001549084"
company_name: "EKSO BIONICS HOLDINGS, INC."
filed_at: "2022-03-10T23:59:59+00:00"
generated_at: "2026-06-26T23:57:46.581407+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Ekso Bionics CCO William Shaw resigns; remains as consultant through June 2022

## Summary
- CCO William Shaw resigns effective March 11, 2022, to join another company.
- Will serve as independent contractor through June 30, 2022, assisting with transition and special projects.
- Entitled to $225/hour or $1,800/day compensation plus Q1 2022 bonus and continued equity vesting.
- Eligible for up to $2,500 per candidate sourced (max two) if hired by company.
- Transition agreement includes standard release of claims and non-disparagement clause.

## SEC filing metadata
- accession: 0001104659-22-032444
- form_type: 8-K
- ticker: CHRN
- cik: 0001549084
- company_name: EKSO BIONICS HOLDINGS, INC.
- filed_at: 2022-03-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549084/000110465922032444/0001104659-22-032444-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549084/000110465922032444/tm228907d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-032444
- JSON: https://secwatch.observer/filing/0001104659-22-032444.json
- Plain text: https://secwatch.observer/filing/0001104659-22-032444.txt

## Key facts
- Executive change
  William Shaw resigned as Chief Commercial Officer at EKSO BIONICS HOLDINGS, INC..
  - Action: resigned
  - Role: Chief Commercial Officer
  source text: William Shaw, the Chief Commercial Officer of Ekso Bionics Holdings, Inc. (the “Company”) notified the Board of Directors (the “Board”) of his intention to resign as Chief Commercial Officer of the Company effective March 11, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000110465922032444/0001104659-22-032444-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.